ArticleBMC nephrology2025
Severe renal haemosiderosis in a patient with untreated paroxysmal nocturnal haemoglobinuria: a case report.
Article in BMC nephrology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundParoxysmal nocturnal haemoglobinuria (PNH) is a life-threatening disease in which intravascular haemolysis of the red blood cells frequently manifests with chronic haemolysis, anaemia and thrombosis. Renal injury in PNH is associated with chronic haemosiderosis and/or microvascular thrombosis. Herein, we describe a case of haemolytic crisis and severe renal haemosiderosis in a patient who was previously treated for aplastic anaemia (AA) and later developed a symptomatic PNH clone. CASE PRESENTATION: A 74-year-old woman with acquired AA treated with immunosuppressive therapy 8 years ago was admitted to our hospital with severe haemolytic anaemia and acute kidney injury in the setting of Escherichia coli sepsis. Peripheral blood flow cytometry demonstrated expansion of the small PNH clone detected at diagnosis with clone size now exceeding 80%. Renal biopsy showed extensive brown pigment deposition in most of the proximal tubules and accompanying severe acute tubular injury. The pigment deposits were confirmed to be haemosiderin on Perls' Prussian blue stain. Based on these biopsy findings and clinical presentation, she was diagnosed with acute tubular injury secondary to Escherichia coli sepsis on a background of chronic kidney disease in part due to chronic intravascular haemolysis associated with untreated PNH. During her admission, she was also found to have large vessel vasculitis and was commenced on high-dose steroids. Her acute haemolysis stabilised after treatment of her sepsis and her renal function also improved. A C5 complement inhibitor was commenced following discharge from hospital.
conclusionOur case illustrates the potentially severe renal complications of acute on chronic intravascular haemolysis associated with untreated, clinical PNH arising from a history of treated AA. Close monitoring and early intervention of patients with symptomatic PNH is therefore critical.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.